What question did this study set out to answer?

This research aims to understand the role of von Willebrand factor in hemostasis and its implications in bleeding and thrombotic disorders.

January 14, 2023Aterotromboz = AtherothrombosisOpen Access

The role of von Willebrand factor in hemostasis pathology

View Full Paper

Ask AI

Bookmark

Authors

YAYuliya AvtaevaNational Medical Research Center of Cardiology IMIvan MelnikovInstitute of Biomedical Problems SVS. A. VasilievNational Medical Research Center for Hematology

Discussion

Member takes

Implication

Randomized trial investigates von Willebrand factor's effects on hemostasis and thrombotic complications in COVID-19, suggesting important diagnostic potential.

Key Points

This research aims to understand the role of von Willebrand factor in hemostasis and its implications in bleeding and thrombotic disorders.
Analyzed von Willebrand factor functionality under high shear rates.
Examined VWF plasma levels and ADAMTS-13 activity in patients with COVID-19.
Evaluated the association between VWF/ADAMTS-13 ratio and thromboembolic risks.
Increased VWF levels and decreased ADAMTS-13 activity observed in severe COVID-19 patients.
High shear rates induce hydrodynamic activation of VWF, enhancing its prothrombotic activity.
The VWF/ADAMTS-13 ratio changes significantly with increased thromboembolic complications.

Cite This Study

Avtaeva et al. (2023) studied this question.

synapsesocial.com/papers/6a63d3b95e88ba7aa33856d9 https://doi.org/10.21518/2307-1109-2022-12-2-79-102

View Full Paper

Ask AI

Bookmark

January 14, 2023Aterotromboz = AtherothrombosisOpen Access

The role of von Willebrand factor in hemostasis pathology

View Full Paper

Ask AI

Bookmark

Authors

YAYuliya AvtaevaNational Medical Research Center of Cardiology IMIvan MelnikovInstitute of Biomedical Problems SVS. A. VasilievNational Medical Research Center for Hematology

Discussion

Member takes

Implication

Randomized trial investigates von Willebrand factor's effects on hemostasis and thrombotic complications in COVID-19, suggesting important diagnostic potential.

Key Points

This research aims to understand the role of von Willebrand factor in hemostasis and its implications in bleeding and thrombotic disorders.
Analyzed von Willebrand factor functionality under high shear rates.
Examined VWF plasma levels and ADAMTS-13 activity in patients with COVID-19.
Evaluated the association between VWF/ADAMTS-13 ratio and thromboembolic risks.
Increased VWF levels and decreased ADAMTS-13 activity observed in severe COVID-19 patients.
High shear rates induce hydrodynamic activation of VWF, enhancing its prothrombotic activity.
The VWF/ADAMTS-13 ratio changes significantly with increased thromboembolic complications.

Cite This Study

Avtaeva et al. (2023) studied this question.

synapsesocial.com/papers/6a63d3b95e88ba7aa33856d9 https://doi.org/10.21518/2307-1109-2022-12-2-79-102

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark